OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Systematic review and meta‐analysis of the moderating effect of rs1799971 in OPRM1, the mu‐opioid receptor gene, on response to naltrexone treatment of alcohol use disorder
Emily E. Hartwell, Richard Feinn, Paige E. Morris, et al.
Addiction (2020) Vol. 115, Iss. 8, pp. 1426-1437
Open Access | Times Cited: 33
Emily E. Hartwell, Richard Feinn, Paige E. Morris, et al.
Addiction (2020) Vol. 115, Iss. 8, pp. 1426-1437
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
The Genetically Informed Neurobiology of Addiction (GINA) model
Ryan Bogdan, Alexander S. Hatoum, Emma C. Johnson, et al.
Nature reviews. Neuroscience (2022) Vol. 24, Iss. 1, pp. 40-57
Closed Access | Times Cited: 28
Ryan Bogdan, Alexander S. Hatoum, Emma C. Johnson, et al.
Nature reviews. Neuroscience (2022) Vol. 24, Iss. 1, pp. 40-57
Closed Access | Times Cited: 28
Medications for treating alcohol use disorder: A narrative review
Henry R. Kranzler, Emily E. Hartwell
Alcohol Clinical and Experimental Research (2023) Vol. 47, Iss. 7, pp. 1224-1237
Closed Access | Times Cited: 17
Henry R. Kranzler, Emily E. Hartwell
Alcohol Clinical and Experimental Research (2023) Vol. 47, Iss. 7, pp. 1224-1237
Closed Access | Times Cited: 17
Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial
Kirsten C. Morley, Henry R. Kranzler, Natasha Luquin, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 5, pp. 403-411
Closed Access | Times Cited: 7
Kirsten C. Morley, Henry R. Kranzler, Natasha Luquin, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 5, pp. 403-411
Closed Access | Times Cited: 7
Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol use disorder endophenotypes
Bankole A. Johnson, Hannu Alho, Giovanni Addolorato, et al.
European Journal of Internal Medicine (2024) Vol. 127, pp. 50-62
Open Access | Times Cited: 4
Bankole A. Johnson, Hannu Alho, Giovanni Addolorato, et al.
European Journal of Internal Medicine (2024) Vol. 127, pp. 50-62
Open Access | Times Cited: 4
Deciphering the Role of Genetics in Alcohol Use Disorder
Evangelia Legaki, Ilias Koutromanos, Leonidas Mantonakis, et al.
(2025), pp. 1-34
Closed Access
Evangelia Legaki, Ilias Koutromanos, Leonidas Mantonakis, et al.
(2025), pp. 1-34
Closed Access
Genetic Variants Associated With Resilience in Human and Animal Studies
Stephanie Cahill, Tarani Chandola, Reinmar Hager
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 19
Stephanie Cahill, Tarani Chandola, Reinmar Hager
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 19
Pharmacotherapies and Personalized Medicine for Alcohol Use Disorder: A Review
Falk W. Lohoff
Pharmacogenomics (2020) Vol. 21, Iss. 15, pp. 1117-1138
Open Access | Times Cited: 25
Falk W. Lohoff
Pharmacogenomics (2020) Vol. 21, Iss. 15, pp. 1117-1138
Open Access | Times Cited: 25
Alcohol and the dopamine system
Bo Söderpalm, Mia Ericson
International review of neurobiology (2024), pp. 21-73
Closed Access | Times Cited: 2
Bo Söderpalm, Mia Ericson
International review of neurobiology (2024), pp. 21-73
Closed Access | Times Cited: 2
The genetic landscape of substance use disorders
Zachary F. Gerring, Jackson G. Thorp, Jorien L. Treur, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 11, pp. 3694-3705
Open Access | Times Cited: 2
Zachary F. Gerring, Jackson G. Thorp, Jorien L. Treur, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 11, pp. 3694-3705
Open Access | Times Cited: 2
Quantile-Specific Heritability of Intakes of Alcohol but not Other Macronutrients
Paul T. Williams
Behavior Genetics (2020) Vol. 50, Iss. 5, pp. 332-345
Open Access | Times Cited: 20
Paul T. Williams
Behavior Genetics (2020) Vol. 50, Iss. 5, pp. 332-345
Open Access | Times Cited: 20
Gabapentin Enacarbil Extended‐Release Versus Placebo: A Likely Responder Reanalysis of a Randomized Clinical Trial
Eugene Laska, Carole Siegel, Ziqiang Lin, et al.
Alcoholism Clinical and Experimental Research (2020) Vol. 44, Iss. 9, pp. 1875-1884
Open Access | Times Cited: 17
Eugene Laska, Carole Siegel, Ziqiang Lin, et al.
Alcoholism Clinical and Experimental Research (2020) Vol. 44, Iss. 9, pp. 1875-1884
Open Access | Times Cited: 17
Association of the OPRM1 A118G polymorphism and Pavlovian-to-instrumental transfer: Clinical relevance for alcohol dependence
Miriam Sebold, Maria Garbusow, Deniz Cerci, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 5, pp. 566-578
Open Access | Times Cited: 13
Miriam Sebold, Maria Garbusow, Deniz Cerci, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 5, pp. 566-578
Open Access | Times Cited: 13
Population-specific genetic background for the OPRM1 variant rs1799971 (118A>G): implications for genomic medicine and functional analysis
Orna Levran, Mary Jeanne Kreek
Molecular Psychiatry (2020) Vol. 26, Iss. 7, pp. 3169-3177
Closed Access | Times Cited: 14
Orna Levran, Mary Jeanne Kreek
Molecular Psychiatry (2020) Vol. 26, Iss. 7, pp. 3169-3177
Closed Access | Times Cited: 14
Developmental Considerations for the Use of Naltrexone in Children and Adolescents
Stephani L. Stancil, Susan M. Abdel‐Rahman, Jon Wagner
The Journal of Pediatric Pharmacology and Therapeutics (2021) Vol. 26, Iss. 7, pp. 675-695
Open Access | Times Cited: 12
Stephani L. Stancil, Susan M. Abdel‐Rahman, Jon Wagner
The Journal of Pediatric Pharmacology and Therapeutics (2021) Vol. 26, Iss. 7, pp. 675-695
Open Access | Times Cited: 12
Post‐treatment effects of topiramate on alcohol‐related outcomes: A combined analysis of two placebo‐controlled trials
Henry R. Kranzler, Richard Feinn, Timothy Pond, et al.
Addiction Biology (2022) Vol. 27, Iss. 2
Open Access | Times Cited: 6
Henry R. Kranzler, Richard Feinn, Timothy Pond, et al.
Addiction Biology (2022) Vol. 27, Iss. 2
Open Access | Times Cited: 6
A Review of the Characteristics of Clinical Trials and Potential Medications for Alcohol Dependence: Data Analysis from ClinicalTrials.gov
Fahad S. Alshehri
Medicina (2023) Vol. 59, Iss. 6, pp. 1101-1101
Open Access | Times Cited: 3
Fahad S. Alshehri
Medicina (2023) Vol. 59, Iss. 6, pp. 1101-1101
Open Access | Times Cited: 3
Pharmakotherapie der Alkoholentwöhnung: Update und neue Entwicklungen
Michael Soyka, Susanne Rösner
Der Nervenarzt (2020) Vol. 92, Iss. 1, pp. 57-65
Open Access | Times Cited: 8
Michael Soyka, Susanne Rösner
Der Nervenarzt (2020) Vol. 92, Iss. 1, pp. 57-65
Open Access | Times Cited: 8
Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial
Raymond F. Anton, Konstantin Voronin, Sarah W. Book, et al.
Alcoholism Clinical and Experimental Research (2020) Vol. 44, Iss. 10, pp. 2084-2096
Open Access | Times Cited: 8
Raymond F. Anton, Konstantin Voronin, Sarah W. Book, et al.
Alcoholism Clinical and Experimental Research (2020) Vol. 44, Iss. 10, pp. 2084-2096
Open Access | Times Cited: 8
Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response
Xiaohu Xie, Jun Gu, Dingding Zhuang, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 11
Open Access | Times Cited: 5
Xiaohu Xie, Jun Gu, Dingding Zhuang, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 11
Open Access | Times Cited: 5
Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: a randomized trial
Joseph P. Schacht, Michaela Hoffman, Brian H. Chen, et al.
The Pharmacogenomics Journal (2021) Vol. 22, Iss. 1, pp. 1-8
Open Access | Times Cited: 6
Joseph P. Schacht, Michaela Hoffman, Brian H. Chen, et al.
The Pharmacogenomics Journal (2021) Vol. 22, Iss. 1, pp. 1-8
Open Access | Times Cited: 6
The effects of acute oral naltrexone pretreatment on the abuse potential of intranasal methamphetamine, and the relationship between reward/punishment sensitivity and methamphetamine’s effects
Jermaine D. Jones, Mudassir Mumtaz, Nehal P. Vadhan, et al.
Behavioural Pharmacology (2022) Vol. 33, Iss. 4, pp. 255-265
Open Access | Times Cited: 4
Jermaine D. Jones, Mudassir Mumtaz, Nehal P. Vadhan, et al.
Behavioural Pharmacology (2022) Vol. 33, Iss. 4, pp. 255-265
Open Access | Times Cited: 4
Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder
João Mauricio Castaldelli‐Maia, André Malbergier, ADRIANA BORGES OLIVEIRA, et al.
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1495-1495
Open Access | Times Cited: 5
João Mauricio Castaldelli‐Maia, André Malbergier, ADRIANA BORGES OLIVEIRA, et al.
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1495-1495
Open Access | Times Cited: 5
Personalized Medicine Through GPCR Pharmacogenomics
Alexander S. Hauser
Elsevier eBooks (2021), pp. 191-219
Closed Access | Times Cited: 4
Alexander S. Hauser
Elsevier eBooks (2021), pp. 191-219
Closed Access | Times Cited: 4
Chemical and Behavioral Addictions
Kris Baetens, Falk Kiefer, Arnt Schellekens, et al.
Cambridge University Press eBooks (2024), pp. 1-18
Closed Access
Kris Baetens, Falk Kiefer, Arnt Schellekens, et al.
Cambridge University Press eBooks (2024), pp. 1-18
Closed Access
AUD in perspective
Andrea de Bejczy, Giovanni Addolorato, Henri‐Jean Aubin, et al.
International review of neurobiology (2024), pp. 1-19
Closed Access
Andrea de Bejczy, Giovanni Addolorato, Henri‐Jean Aubin, et al.
International review of neurobiology (2024), pp. 1-19
Closed Access
